UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Radioimmunotherapy of Lymphoma: Bexxar and Zevalin

Seminars in nuclear medicine, 2010-03, Vol.40 (2), p.122-135

Goldsmith, Stanley J., MD

2010

Volltextzugriff (PDF)

Phase II Study of Lutetium-177―Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2013-09, Vol.19 (18), p.5182-5191

2013

Volltextzugriff (PDF)

Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis

Blood, 2013-09, Vol.122 (11), p.1881-1886

2013

Volltextzugriff (PDF)

Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma

The journal of clinical endocrinology and metabolism, 2018-01, Vol.103 (1), p.213-220

2018

Volltextzugriff (PDF)

Targeted Radionuclide Therapy: A Historical and Personal Review

Seminars in nuclear medicine, 2020-01, Vol.50 (1), p.87-97

Goldsmith, Stanley J.

2020

Volltextzugriff (PDF)

First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer

Journal of Nuclear Medicine, 2013-03, Vol.54 (3), p.380-387

2013

Volltextzugriff (PDF)

Clinical role of FDG PET in evaluation of cancer patients

Radiographics, 2003-03, Vol.23 (2), p.315-340

2003

Volltextzugriff (PDF)

Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors

Journal of clinical oncology, 2007-02, Vol.25 (5), p.540-547

2007

Volltextzugriff (PDF)

Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer

Journal of clinical oncology, 2004-07, Vol.22 (13), p.2522-2531

2004

Volltextzugriff (PDF)

FDG‐PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease

Cancer, 2006-12, Vol.107 (11), p.2678-2687

2006

Volltextzugriff (PDF)

Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7565-7573

2005

Volltextzugriff (PDF)

Clinically Proven Radiopharmaceuticals for Infection Imaging: Mechanisms and Applications

Seminars in nuclear medicine, 2009, Vol.39 (1), p.2-10

2009

Volltextzugriff (PDF)

PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake

Radiographics, 2004-09, Vol.24 (5), p.1411-1431

2004

Volltextzugriff (PDF)

PET/CT Imaging and Radioimmunotherapy of Prostate Cancer

Seminars in nuclear medicine, 2011, Vol.41 (1), p.29-44

2011

Volltextzugriff (PDF)

Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma

Surgery, 2008-12, Vol.144 (6), p.942-948

2008

Volltextzugriff (PDF)

Abbreviated Chemotherapy With Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab for Untreated Follicular Lymphoma

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5696-5704

2005

Volltextzugriff (PDF)

Guest Editorial: Skeletal Nuclear Medicine

Seminars in nuclear medicine, 2015, Vol.45 (1), p.2-2

2015

Volltextzugriff (PDF)

Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer

Cancer, 2019-08, Vol.125 (15), p.2561-2569

2019

Volltextzugriff (PDF)

Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma

Cancer, 2002-02, Vol.94 (4), p.879-888

2002

Volltextzugriff (PDF)

Cyclophosphamide, Vincristine, and Prednisone Followed by Tositumomab and Iodine-131–Tositumomab in Patients With Untreated Low-Grade Follicular Lymphoma: Eight-Year Follow-Up of a Multicenter Phase II Study

Journal of clinical oncology, 2010-06, Vol.28 (18), p.3035-3041

2010

Volltextzugriff (PDF)

PET Imaging of Leptin Biodistribution and Metabolism in Rodents and Primates

Cell metabolism, 2009-08, Vol.10 (2), p.148-159

2009

Volltextzugriff (PDF)

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum

Pancreas, 2010-08, Vol.39 (6), p.753-766

2010

Volltextzugriff (PDF)

Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancer

Frontiers in oncology, 2013-01, Vol.3, p.214-214

2013

Volltextzugriff (PDF)

99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer

The Journal of nuclear medicine (1978), 2014-11, Vol.55 (11), p.1791-1798

2014

Volltextzugriff (PDF)

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas

Pancreas, 2010-08, Vol.39 (6), p.735-752

2010

Volltextzugriff (PDF)

1 – 25 von 340

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(253)

Publikationsform

Sprache

Englisch
(340)

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Life Sciences & Biomedicine
(180)
Humans
(178)
Radiology, Nuclear Medicine & Medical Imaging
(111)
Male
(97)
Female
(89)
Biological And Medical Sciences
(78)
Radionuclide Imaging
(76)
Medical Sciences
(75)
Middle Aged
(71)
Adult
(67)
Aged
(50)
Animals
(35)
Investigative Techniques, Diagnostic Techniques
(28)
Oncology
(25)
Time Factors
(25)
Radionuclide Investigations
(23)
Radiopharmaceuticals
(23)
Aged, 80 And Over
(22)
Indium Radioisotopes
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Radioimmunotherapy of Lymphoma: Bexxar and Zevalin

Phase II Study of Lutetium-177―Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis

Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma

Targeted Radionuclide Therapy: A Historical and Personal Review

First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer

Clinical role of FDG PET in evaluation of cancer patients

Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors

Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer

FDG‐PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease

Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas

Clinically Proven Radiopharmaceuticals for Infection Imaging: Mechanisms and Applications

PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake

PET/CT Imaging and Radioimmunotherapy of Prostate Cancer

Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma

Abbreviated Chemotherapy With Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab for Untreated Follicular Lymphoma

Guest Editorial: Skeletal Nuclear Medicine

Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer

Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma

Cyclophosphamide, Vincristine, and Prednisone Followed by Tositumomab and Iodine-131–Tositumomab in Patients With Untreated Low-Grade Follicular Lymphoma: Eight-Year Follow-Up of a Multicenter Phase II Study

PET Imaging of Leptin Biodistribution and Metabolism in Rodents and Primates

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum

Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancer

99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas

Suchergebnisse filtern